INTELLIGENT BIO SOLUTIONS IN (INBS)
US36151G6008 - Common Stock
INTELLIGENT BIO SOLUTIONS IN
NASDAQ:INBS (1/14/2025, 8:00:02 PM)
Premarket: 1.32 +0.02 (+1.54%)1.3
-0.02 (-1.52%)
Company Profile
Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. The company is headquartered in New York City, New York and currently employs 13 full-time employees. The company went IPO on 2020-12-23. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Company Info
INTELLIGENT BIO SOLUTIONS IN
135 W 41St St,, Floor 5
New York City NEW YORK
P: 16462336971
Employees: 13
Website: https://ibs.inc/
INBS News
a day ago - Intelligent Bio Solutions, Inc.Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK SitesPrincebuild has moved from saliva testing to INBS' fingerprint drug testing solution to implement a more streamlined, in-house solution across seven...
a month ago - Intelligent Bio Solutions, Inc.Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening TechnologyNEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (
a month ago - Intelligent Bio Solutions, Inc.Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ETNEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company...
2 months ago - Intelligent Bio Solutions, Inc.Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study ResultsIntelligent Fingerprinting Drug Screening System on path to FDA 510(k) submission, expected in the fourth calendar quarter of 2024 INBS will include data...
2 months ago - Intelligent Bio Solutions, Inc.Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity ConferenceNEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company...
2 months ago - Intelligent Bio Solutions, Inc.Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational HighlightsQuarterly revenue increased 10% year-on-year and 20% quarter-on-quarter, marking four consecutive quarters of year-on-year growth Higher-margin,...
INBS Twits
Here you can normally see the latest stock twits on INBS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
